Titlebook: Retinal Vascular Disease; Alan Sheyman,Amani A. Fawzi Book 2020 Springer Nature Singapore Pte Ltd. 2020 Diabetic retinopathy.Takayasu arte

毛發(fā)

書目名稱Retinal Vascular Disease影響因子(影響力)




書目名稱Retinal Vascular Disease影響因子(影響力)學科排名




書目名稱Retinal Vascular Disease網絡公開度




書目名稱Retinal Vascular Disease網絡公開度學科排名




書目名稱Retinal Vascular Disease被引頻次




書目名稱Retinal Vascular Disease被引頻次學科排名




書目名稱Retinal Vascular Disease年度引用




書目名稱Retinal Vascular Disease年度引用學科排名




書目名稱Retinal Vascular Disease讀者反饋




書目名稱Retinal Vascular Disease讀者反饋學科排名

Silent-Ischemia

https://doi.org/10.1007/978-981-15-4075-2Diabetic retinopathy; Takayasu arteritis; Coats’ disease; Susac syndrome; Eales’ disease

混雜人

Branch Retinal Vein Occlusion,Branch retinal vein occlusion (BRVO) was first described in 1855 as a “retinal apoplexy” by Liebreich (Liebreich 1855) and as thrombotic in nature by von Michel in 1878 (von Michel 1878).

現代

Irksome

978-981-15-4077-6Springer Nature Singapore Pte Ltd. 2020

謊言

monogamy

Central Retinal Artery Occlusion,icant visual loss. RAO was first described by von Graefe’s report as multiple systemic emboli in a patient affected by endocarditis that caused an obstruction of the central retinal artery (von Graefes 1859).

使顯得不重要

Imaging of Retinal Vascular Disease,tery (Jakobiec 1982). In up to 32% of the eyes (Justice and Lehmann 1976), an additional branch, the cilioretinal artery, may extend from the choroidal circulation to supply a portion of the inner retina, mainly in the macular region.

resuscitation

Artificial Intelligence in Retinal Vascular Imaging,able of learning through exposure to large amounts of data. Ophthalmology, and especially retinal science, are at the forefront of AI applications in medicine, with a fully autonomous AI image-based diagnostic system that has recently been approved by the FDA as a first of its kind in medicine (Abramoff et al. 2018; Topol 2019).

Derogate

Sickle Cell Retinopathy,otein results in sickling of erythrocytes, intravascular hemolysis, defective oxygen transport, and tissue damage due to ischemia and necrosis. Sickle cell disease manifests systemically in many organs such as the brain, lungs, heart, liver, spleen, kidneys, joints, bones, and skin (Yawn et al. 2014).